Clinical Trials
9 trialsNCT00615784 2020-12-17
UPCC04407
Abramson Cancer Center at Penn Medicine
Phase 2 Terminated
NCT00411632 2020-01-29
BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00153842 2019-03-06
A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer
Dartmouth-Hitchcock Medical Center
Phase 1/2 Terminated
NCT00125359 2019-01-08
Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer
Dartmouth-Hitchcock Medical Center
Phase 2 Completed
NCT00125372 2019-01-08
Study of Tarceva and Targretin in Stage I-II Lung Cancer
Dartmouth-Hitchcock Medical Center
Phase NA Completed
NCT00425477 2018-10-05
Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00255801 2018-08-16
Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00178841 2016-02-17
Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL
Vanderbilt University
Phase 2 Completed
NCT00718770 2014-01-17
A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression
University of Colorado, Denver
Phase EARLY_PHASE1 Completed